Sanofi | SNY - Assets


Sanofi reported EUR129.06B in Assets for its fiscal quarter ending in June of 2026.





Assets Change Date
AbbVie USD 147.68B 12.57B Sep/2026
Amgen USD 96.05B 409M Sep/2026
AstraZeneca USD 119.92B 4.09B Sep/2026
Bristol-Myers Squibb USD 88.77B 1.14B Sep/2026
Canopy Growth CAD 1.1B 14.81M Jun/2026
Corcept Therapeutics USD 1.03B 145.32M Sep/2026
Drreddys Laboratories INR 574.48B 4.86B Sep/2026
Eli Lilly USD 148.07B 5.79B Sep/2026
Genmab DKK 12.52B 139M Jun/2026
GlaxoSmithKline GBP 71.7B 9.96B Sep/2026
Glaxosmithkline GBP 71.7B 8.83B Sep/2026
J&J USD 197.42B 3.64B Sep/2026
Lakefront Biotherapeutics EUR 3.35B 21.24M Jun/2026
Merck USD 132.77B 2.97B Sep/2026
Novartis USD 117.15B 4.88B Sep/2026
Novartis USD 117.15B 1.38B Sep/2026
Pacira USD 34.68B 33.44B Sep/2026
Perrigo USD 7.48B 124.6M Sep/2026
Pfizer USD 204.54B 3.41B Sep/2026
Phibro Animal Health USD 1.51B 13.48M Sep/2026
Prestige Brands USD 4.72B 153.09M Sep/2026
Roche Holding CHF 98.2B 2.5B Jun/2026
Sanofi EUR 130.29B 1.23B Sep/2026
Sanofi EUR 129.06B 1.04B Jun/2026
Supernus Pharmaceuticals USD 1.4B 30.42M Sep/2026
UCB EUR 18.16B 971M Dec/2025
Zoetis USD 15.09B 11M Sep/2026